English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 855662 Online Users : 1302
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
National Institute of Cancer Research
Kelvin Kun-Chih Tsai
--Conference Papers/Meeting Abstract
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
NHRI
>
National Institute of Cancer Research
>
Kelvin Kun-Chih Tsai
>
Conference Papers/Meeting Abstract
>
Browse By Title
Browse By Authors
Browse By Date
Browse By Data Type
Loading...
Siblings
Periodical Articles
[
27
/27]
Collection Statistics
Item counts issued in 3 years:0(0.00%)
Items With Fulltext:5(71.43%)
Download counts of the item
Download times greater than 0:5(100.00%)
Download times greater than 100:5(100.00%)
Total Bitstream Download Counts:1981(14.14%)
Last Update: 2024-11-28 19:48
Top Upload
Loading...
Top Download
Loading...
Recent Submissions
Multicenter, phase II trial of biwe...
ACTL6a promotes metastasis and pred...
Targeting PTX3 can prevent drug-res...
NCoR2 mediates death-resistance and...
Phase I trial of biweekly S-1, leuc...
Proteomics profiling of epigenetic ...
A molecular signature of tubulogene...
Jump to a point in the index:
(Choose year)
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(Choose month)
January
February
March
April
May
June
July
August
September
October
November
December
Or type in a year:
Ordering With Most Recent First
Show Oldest First
Showing items 1-7 of 7. (1 Page(s) Totally)
1
View [
10
|
25
|
50
] records per page
Date
Title
Relation
2018-12
ACTL6a promotes metastasis and predicts poor prognosis of prostate cancer via regulation of YAP and cancer stemness
Cancer Science. 2018 Dec;109(Suppl. 2):244.
2018-11
Targeting PTX3 can prevent drug-resistant cancer progression
Protein Science. 2018 Nov;27(Suppl. 1):24.
2018-10
Multicenter, phase II trial of biweekly S-1, leucovorin (LV), oxaliplatin and gemcitabine (SLOG) in metastatic pancreatic adenocarcinoma (mPDAC): Final report of TCOG T1211 study
Annals of Oncology. 2018 Oct;29(Suppl. 8):Meeting Abstract 736P.
2016-12
NCoR2 mediates death-resistance and mechano-regulation of glioblastoma multiforme
Molecular Biology of the Cell. 2016 Dec;27:Meeting Abstract P1160.
2016-02
Phase I trial of biweekly S-1, leucovorin, oxaliplatin, and gemcitabine (the SLOG regimen) in metastatic pancreatic adenocarcinoma (mPDAC)
Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 369.
2015-11
Proteomics profiling of epigenetic proteins during acinar morphogenesis to identify prostate cancer prognostic markers
Annals of Oncology. 2015 Nov;26:vii106-vii151.
2012-12
A molecular signature of tubulogenesis in pancreatic cancer and oncogenic role of ASPM
Molecular Biology of the Cell. 2012 Dec;23:Article number 1631.
Showing items 1-7 of 7. (1 Page(s) Totally)
1
View [
10
|
25
|
50
] records per page
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
Feedback